Why Advanced Therapies Can't Scale?

The Hidden Problem With Gene Therapy

Why is gene therapy still so hard to scale? Tara Austraat-Churik explains that the biggest challenge isn’t discovery. It's manufacturing. Many cell and gene therapies are built for one individual at a time, making large-scale production incredibly difficult.

From facility limitations to chemistry, manufacturing, and control (CMC), biotech innovation often gets stuck between breakthrough science and real-world delivery.

👉 Follow for AI, biotech, and healthcare innovation insights

#GeneTherapy #Biotech #HealthcareInnovation #Pharma #CellTherapy #CRISPR #DrugDevelopment #MedicalInnovation #BiotechStartups #FutureOfMedicine